The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood

Addiction

Volumn 108, Issue 1, 2013, Pages 124-133

  Degenhardt, Louisa ^a,b   Coffey, Carolyn ^b   Romaniuk, Helena ^b   Swift, Wendy ^a   Carlin, John B ^b   Hall, Wayne D ^c   Patton, George C ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Anxiety; Cannabis; Cohort; Depression; Epidemiology; Psychiatry

Indexed keywords

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CANNABIS ADDICTION; CANNABIS SMOKING; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR DEPRESSION; MALE; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; YOUNG ADULT;

EID: 84871681214     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04015.x     Document Type: Article

References (43)

1. Degenhardt L., Hall W., Lynskey M. The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 219-227.
2. Harder V., Stuart E., Anthony J. C. Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. Am J Epidemiol 2008; 168: 592-601.
3. Fleming C. B., Mason W. A., Mazza J. J., Abbott R. D., Catalano R. F. Latent growth modeling of the relationship between depressive symptoms and substance use during adolescence. Psychol Addict Behav 2008; 22: 186-197.
4. van Laar M., van Dorsselaer S., Monshouwer K., de Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction 2007; 102: 1251-1260.
5. Hayatbakhsh M., Najman J. M., Jamrozik K. etal. Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry 2007; 46: 408-417.
6. Wittchen H.-U., Frohlich C., Behrendt S. etal. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007; 88: S60-70.
7. de Graaf R., Radovanovic M., van Laar M., Fairman B., Degenhardt L., Aguilar-Gaxiola S. et al. Early cannabis use and estimated risk of later onset of depression spells: epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. Am J Epidemiol 2010; 172: 149-159.
8. Degenhardt L., Hall W., Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003; 98: 1493-1504.
9. Patton G., Coffey C., Carlin J. etal. Cannabis use and mental health in young people: cohort study. BMJ 2002; 325: 1195-1198.
10. Crippa J. A., Zuardi A. W., Martín Santos R. etal. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol 2009; 24: 515-523.
11. Moore T., Zammit S., Lingford-Hughes A., Barnes T., Jones P., Burke M. et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. The Lancet 2007; 370: 319-328.
12. Windle M., Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Dev Psychopathol 2004; 16: 1007-1027.
13. Schneider M. Review for special issue on cannabinoids: puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol 2008; 13: 253-263.
14. Malone D. T., Hill M. N., Rubino T. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol 2010; 160: 511-522.
15. Rodriguez Bambico F., Duranti A., Tontini A., Tarzia G., Gobbi G. Endocannabinoids in the treatment of mood disorders: evidence from animal models. Curr Pharm Des 2009; 15: 1623-1646.
16. Sundram S. Cannabis and neurodevelopment: implications for psychiatric disorder. Hum Psychopharmacol 2006; 21: 245-254.
17. Paperny D., Aono J., Lehman R., Hammar S., Risser J. C. Computer-assisted detection and intervention in adolescent high-risk health behaviours. J Paediatr 1990; 116: 456-462.
18. Lewis G., Pelosi A. J., Glover E. etal. The development of a computerised assessment for minor psychiatric disorder. Psychol Med 1988; 18: 737-745.
19. Lewis G., Williams P. Clinical judgement and the standardized interview in psychiatry. Psychol Med 1989; 19: 971-979.
20. Harrington R., Fudge H., Rutter M., Pickles A., Hill J. Adult outcomes of childhood and adolescent depression: II. Links with antisocial disorders. J Am Acad Child Adolesc Psychiatry 1991; 30: 434-439.
21. Lewis G., Pelosi A., Araya R., Dunn G. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med 1992; 22: 465-486.
22. World Health Organization. Composite International Diagnostic Interview (CIDI) Core Version 2.1, 12-month version. Geneva: World Health Organization; 1997.
23. Kessler R. C., Andrews G., Mroczek D., Ustun B., Wittchen H. U. The World Health Organization Composite International Diagnostic Interview-Short Form (CIDI-SF). Int J Methods Psychiatr Res 1998; 7: 171-185.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association; 1994.
25. Goldberg D. The Detection of Psychiatric Illness by Questionnaire. London: Oxford University Press; 1972.
26. Rubin D. B. Multiple Imputation for Non-Response in Surveys. New York: John Wiley and Sons; 1987.
27. STATA Corporation. STATA/SE version 11.1. College Station, Texas: STATA Corporation; 2009.
28. Bernaards C. A., Belin T. R., Schafer J. L. Robustness of a multivariate normal approximation for imputation of incomplete binary data. Stat Med 2007; 26: 1368-1382.
29. Swain N. R., Gibb S. J., Horwood L., Fergusson D. M. Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young adulthood. Drug Alcohol Rev 2012; 31: 327-333.
30. Mueser K. T., Drake R. E., Wallach M. A. Dual diagnosis: a review of etiological theories. Addict Behav 1998; 23: 717-734.
31. Kessler R. C. Epidemiology of psychiatric comorbidity. In: Tsuang M. T., Tohen M., Zahner G. E. P., editors. Textbook in Psychiatric Epidemiology. New York: Wiley and Sons; 1995, p. 179-197.
32. Caron C., Rutter M. Comorbidity in child psychopathology: concepts, issues and research strategies. J Child Psychol Psychiatry 1991; 32: 1063-1080.
33. Institute of Medicine. Pathways of Addiction. Washington, DC: National Academy Press; 1996.
34. Weissman M., Livingston Bruce M., Leaf P., Florio L., Holzer C. Affective disorders. In: Robins L., Regier D., editors. Psychiatric Disorders in America. New York: MacMillan; 1991, p. 53-80.
35. Blazer D. Mood disorders: epidemiology. In: Kaplan H., Sadock B., editors. Comprehensive Textbook of Psychiatry. Baltimore, MA: Williams and Wilkins; 1995, p. 1079-1089.
36. Kessler R. C., McGonagle K. A., Zhao S. etal. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
37. Jablensky A., Sartorius N., Ernberg G. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization Ten-Country Study. Psychological Medicines Supplement no. 20; 1991.
38. Fergusson D., Horwood J., Lawton M. Vulnerability to childhood problems and family social background. J Child Psychol Psychiatry 1990; 31: 1145-1160.
39. Fergusson D., Horwood L., Lynskey M. Parental separation, adolescent psychopathology and problem behaviours. J Am Acad Child Adolesc Psychiatry 1994; 33: 1122-1131.
40. Rutter M. Parental mental disorder as a psychiatric risk factor. In: Hales R., Frances A., editors. Psychiatric Update: American Psychiatric Association: Annual Review. Washington, DC: American Psychiatric Press; 1987, p. 647-663.
41. Velez C., Johnson J., Cohen P. A longitudinal analysis of selected risk factors for childhood psychopathology. J Am Acad Child Adolesc Psychiatry 1989; 28: 861-864.
42. Patel S., Roelke C. T., Rademacher D. J., Cullinan W. E., Hillard C. J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004; 145: 5431-5438.
43. Huizink A. C., Ferdinand R. F., Ormel J., Verhulst F. C. Hypothalamic-pituitary-adrenal axis activity and early onset of cannabis use. Addiction 2006; 101: 1581-1588.